学习工作经历 |
学习经历: 2016-09 至 2020-06, 浙江大学, 内科学, 博士 2013-09 至 2016-07, 温州医科大学, 临床检验诊断学, 硕士 2008-09 至 2013-07, 长治医学院, 医学检验, 学士 工作经历: 2021-01 至今, 山西医科大学, 第一临床医学院, 医师 |
代表性成果 (论文/专利/专著等) |
(1)Jingfen Zhang , Qiaoyu Li , Jingjing Liu , Fangfang Fan , Yiwei Shi, Xiao Yu Prevalence of Hypervirulent Klebsiella pneumoniae Strains inCOVlD-19 Patients with Bacterial Co-infections, 2025, Front. Microbiol. 16:1535893.doi: 10.3389/fmicb.2025.1535893 (2)Xiao Yu, Tao Xiong, Lu Yu, Gaisheng Liu, Fan Yang, Xueqin Li, Yangyang Wei, Xiaojing Wang, Shuting Wei, Yi Jiang, Xiaomei Kong, Shouan Ren, Yiwei Shi. Gut microbiome and metabolome profiling in coal workers' pneumoconiosis: potential links to pulmonary function. Microbiology spectrum. 2024 Sep 16:e0004924. doi: 10.1128/spectrum.00049-24. Epub ahead of print. PMID: 39283109. (3)Zhan Qing, Teng Gaoqin, Chen Weiwei, Yu Xiao. High prevalence of ST5-SCCmec II-t311 clone of methicillin-resistant Staphylococcus aureus isolated from bloodstream infections in East China. BMC Microbiology. 2024 Mar 16;24(1):89. doi: 10.1186/s12866-024-03232-5. PMID: 38491414; PMCID: PMC10943896. (4)Lu Hong, Cheng Li, Cui Shu, Yi Xin, Li Xueqin, Liu Xiang, Kong Xiaomei, Yu Xiao. Characterizing the Loss and Acquisition of Tn2-like Transposon in Klebsiella pneumoniae: Implications for Carbapemase Gene Dissemination. Journal of Global Antimicrobial Resistance. 2024 May 6: 38, 98–102. doi: 10.1016/j.jgar.2024.04.011. Epub ahead of print. PMID: 38719187. (5)Xiao Yu, Li Cheng, Xin Yi, Bing Li, Xueqin Li, Xiang Liu, Zhihong Liu, Xiaomei Kong. Gut phageome: challenges in research and impact on human microbiota. Frontiers in Microbiology. 2024 Mar 22;15:1379382. doi: 10.3389/fmicb.2024.1379382. PMID: 38585689; PMCID: PMC10995246. (6)Yi Xin, Lu Hong, Liu Xiang, He Junyi, Li Bing, Wang Zhelong, Zhao Yujing, Zhang Xinri, Yu Xiao. Unravelling the enigma of the human microbiome: Evolution and selection of sequencing technologies. Microbial Biotechnology. 2024 Jan;17(1):e14364. doi: 10.1111/1751-7915.14364. Epub 2023 Nov 6. PMID: 37929823; PMCID: PMC10832515. (7)Zhang Chenwei, Xi Yujia, Zhang Yukai, He Peiyun, Su Xuesen, Li Yishan, Zhang Mengyuan, Liu Haizhao, Yu Xiao, Shi Yiwei. Causal effects between gut microbiota and pulmonary arterial hypertension: A bidirectional Mendelian randomization study. Heart Lung. 2024 Mar-Apr;64:189-197. doi: 10.1016/j.hrtlng.2024.01.002. Epub 2024 Jan 29. PMID: 38290183. (8)Yu Xiao; Jin Ye; Zhou Wangxiao; Xiao Tingting; Wu Zhongwen; Su Junwei; Gao Hainv; Shen Ping; Zheng Beiwen; Luo Qixia; Li lanjuan; Xiao Yonghong ; Rifaximin Modulates the Gut Microbiota to Prevent Hepatic Encephalopathy in Liver Cirrhosis Without Impacting the Resistome,Frontiers in Cellular and Infection Microbiology,2022,11(76) (9)Yu Xiao; Zheng Beiwen; Xiao,Feng; Jin Ye; Guo Lihua; Xu Hao; Luo Qixia; Xiao Yonghong ; Effect of Short-Term Antimicrobial Therapy on the Tolerance and Antibiotic Resistance of Multidrug-Resistant Staphylococcus capitis,Infection and Drug Resistance,2020,13: 2017-2026 (10)Yu Xiao; Zheng Beiwen; Zhang Jing; Xu Hao; Xiao Tingting; Zhou Yanzi; Zhang Shunti an; Zhu Yunying; Wang Yuan; Xiao Yonghong ; Comprehensive Genome Analysis of Carbapenem-Resist ant Strains of Raoultella Species,an Emerging Multidrug-Resistant Bacterium in Hospitals,Antimicrobial Agents and Chemotherapy,2019,63(12): e01367-19 |